Current Edition

Biopharma

Roche recalls new eye therapy Susvimo on leakage fears, aims for market return ‘within a year or so’

Just as doctors were starting to cozy up to Roche and Genentech’s new eye drug delivery therapy, the companies are pulling the product from U.S. …

Continue Reading →
Biopharma

Love Pharma moves to buy transdermal opioid-use disorder player

Love Pharma has struck a deal to acquire transdermal drug delivery technology, signing a letter of intent to buy Naltrexone Therapeutics for intellectual property covering …

Continue Reading →
bioLIVE

bioLIVE to introduce global biopharma country ranking

Global analysis will rank each major biomanufacturing country’s market growth potential, innovation and competitiveness The UBM bioprocessing and manufacturing event opening in October (9-11) in …

Continue Reading →
Biopharma

Loncar introduces China BioPharma Index

LCHINA is the first and only stock market index available to the public that follows China’s biopharma industry from both its regional and U.S. listed …

Continue Reading →